Thaçi, D, Puig, L, Papp, K, Gold, LS, Fernández-Peñas, P, Huang, YH, Dossenbach, M, Falques, M, Agell, H, Schönherr, F, Vestergaard, C. Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).

Ton, V, Najjar, E, Yehya, A, Bernhardt, A, Sokolski, M, Hrytsyna, Y, Knierim, J, Schlöglhofer, T, Caliskan, K, Zimpfer, D, Perez, SM, Kanwar, M, Patel, S, Potapov, E. Global Survey of Left Ventricular Assist Device (LVAD) Wean Protocols: A VAD Wean Registry Report. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2025; 44(4)DOI:. PMID:. IF:6.000(Q1/1D).

Jiménez-Blanco, M, Crespo-Leiro, MG, Carmena, MDGC, Bueno, MG, López-Vilella, R, Ortiz-Bautista, C, Farrero-Torres, M, Zegrí-Reiriz, I, Díaz-Molina, B, García-Romero, E, Rangel-Sousa, D, Salterain, N, Bravo, IG, Segovia-Cubero, J. Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR). JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2025; 44(4)DOI:10.1016/j.healun.2024.11.009. PMID:39577511. IF:6.000(Q1/1D).

Krychtiuk, KA, Sionis, A. Development and external validation of a deep learning electrocardiogram model for risk stratification of coronary revascularization need in the emergency department. European Heart Journal-Acute Cardiovascular Care. 2025; 14(4)DOI:10.1093/ehjacc/zuaf058. PMID:40192550. IF:4.600(Q1/2D).